Garcia Marino has filed 16 insider transactions across 1 company since January 2024.
Most recent transaction: a option exercise of 59700 shares of Dianthus Therapeutics, Inc. /DE/ ($DNTH) on March 16, 2026.
Activity breakdown: 0 open-market purchases and 5 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | Garcia Marino | CEO AND PRESIDENT | M | Common Stock | 59700 | $6.70 | 59,700.0000 | 42,876,015 | 9999.99% | 0.14% |
| March 16, 2026 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | Garcia Marino | CEO AND PRESIDENT | M | Common Stock | 5592 | $17.88 | 65,292.0000 | 42,876,015 | 9.37% | 0.01% |
| March 16, 2026 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | Garcia Marino | CEO AND PRESIDENT | M | Stock Option (Right to Buy) | 59700 | $0.00 | 41.0000 | 42,876,015 | 99.93% | 0.14% |
| March 16, 2026 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | Garcia Marino | CEO AND PRESIDENT | M | Stock Option (Right to Buy) | 5592 | $0.00 | 269,408.0000 | 42,876,015 | 2.03% | 0.01% |
| March 12, 2026 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | Garcia Marino | CEO AND PRESIDENT | S | Common Stock | 12796 | $82.60 | 1,100.0000 | 42,876,015 | 92.08% | 0.03% |
| March 12, 2026 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | Garcia Marino | CEO AND PRESIDENT | M | Common Stock | 122918 | $6.70 | 122,918.0000 | 42,876,015 | 9999.99% | 0.29% |
| March 12, 2026 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | Garcia Marino | CEO AND PRESIDENT | S | Common Stock | 65517 | $81.74 | 13,896.0000 | 42,876,015 | 82.50% | 0.15% |
| March 12, 2026 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | Garcia Marino | CEO AND PRESIDENT | S | Common Stock | 43505 | $80.69 | 79,413.0000 | 42,876,015 | 35.39% | 0.10% |
| March 12, 2026 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | Garcia Marino | CEO AND PRESIDENT | M | Stock Option (Right to Buy) | 122918 | $0.00 | 59,741.0000 | 42,876,015 | 67.29% | 0.29% |
| March 12, 2026 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | Garcia Marino | CEO AND PRESIDENT | S | Common Stock | 900 | $85.53 | 0.0000 | 42,876,015 | 100.00% | 0.00% |
| March 12, 2026 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | Garcia Marino | CEO AND PRESIDENT | S | Common Stock | 200 | $83.38 | 900.0000 | 42,876,015 | 18.18% | 0.00% |
| Feb. 3, 2026 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | Garcia Marino | CEO AND PRESIDENT | A | Stock Option (Right to Buy) | 355000 | $0.00 | 355,000.0000 | 42,876,015 | 9999.99% | 0.83% |
| Sept. 30, 2025 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | Garcia Marino | CEO AND PRESIDENT | A | Stock Option (Right to Buy) | 120000 | $0.00 | 120,000.0000 | 32,125,179 | 9999.99% | 0.37% |
| Feb. 3, 2025 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | Garcia Marino | CEO AND PRESIDENT | A | Stock Option (Right to Buy) | 340000 | $0.00 | 340,000.0000 | 0 | 9999.99% | 0.00% |
| May 23, 2024 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | Garcia Marino | CEO AND PRESIDENT | A | Stock Option (Right to Buy) | 243000 | $0.00 | 243,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 24, 2024 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | Garcia Marino | CEO AND PRESIDENT | A | Stock Option (Right to Buy) | 275000 | $0.00 | 275,000.0000 | 0 | 9999.99% | 0.00% |